The Georgian Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Georgian Health Digest.

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Press releases published on December 1, 2025

December 1, 2025

BioCardia to Present at December 2025 CSI Focus Devices in Heart Failure Congress

GlobeNewswire

December 1, 2025

MannKind Announces U.S. FDA Accepts for Review its Supplemental New Drug Application (sNDA) of FUROSCIX ReadyFlow™ Autoinjector for the Treatment of Edema in Adults with Chronic Heart Failure or Chronic Kidney Disease

GlobeNewswire

December 1, 2025

NRx Pharmaceuticals (NASDAQ:NRXP) and HOPE Therapeutics to Present at NobleCon21 - Noble Capital Markets’ Twenty First Annual Emerging Growth Equity Conference

GlobeNewswire

December 1, 2025

Philips expands commercial availability of world’s first real-time AI-enabled light-based 3D navigation solution for image-guided therapy

GlobeNewswire

December 1, 2025

Solid Biosciences Receives FDA Rare Pediatric Disease Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich’s Ataxia

GlobeNewswire

December 1, 2025

Cocrystal Pharma to Present at the Noble Capital Markets’ 21st Emerging Growth Equity Conference

GlobeNewswire

December 1, 2025

Cerevance to Participate in RBC Capital Markets 2025 Healthcare Private Company Conference

GlobeNewswire

December 1, 2025

Connect Strengthens Leadership Team with Promotion of Cait Kelly to Chief Strategy Officer

GlobeNewswire

December 1, 2025

INmune Bio Reports New Phase 2 Grey Matter Imaging Data at CTAD Conference Reinforcing XPro1595’s Evidence Base in High-Inflammation Alzheimer's Patients

GlobeNewswire

December 1, 2025

Daré Bioscience Announces Return of Rights to Ovaprene®; Phase 3 Program Ongoing; Positive Interim Data and Grant Funding Position Asset for Value-Maximization

GlobeNewswire

December 1, 2025

Sutro Biopharma Announces 1-for-10 Reverse Stock Split

GlobeNewswire

December 1, 2025

Zwanger-Pesiri Radiology Implements Konica Minolta Healthcare’s Bone Suppression Imaging Technology to Enhance Chest X-ray Diagnoses

GlobeNewswire

December 1, 2025

O2matic’s Autonomous Oxygen Therapy Technology to Be Evaluated in U.S. Prehospital Study Funded by Department of Defense

GlobeNewswire

December 1, 2025

Catheter Precision Announces Launch of LockeT in Switzerland

GlobeNewswire

December 1, 2025

Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions

GlobeNewswire

December 1, 2025

Ascentage Pharma to Host Webcast Highlighting Key Data from ASH 2025

GlobeNewswire

December 1, 2025

BioNexus Gene Lab Corp. (Nasdaq: BGLC) and Fidelion Diagnostics Execute Exclusive Southeast Asia License for VitaGuard™ MRD Platform as Part of Strategic Alliance with Tongshu Gene

GlobeNewswire

December 1, 2025

Tectonic Therapeutic to Participate in December Investor Conferences

GlobeNewswire

December 1, 2025

Plus Therapeutics to Present ReSPECT Phase 1 Dose Escalation Study Results for Leptomeningeal Metastases at the 2025 San Antonio Breast Cancer Symposium

GlobeNewswire

December 1, 2025

Medicus Pharma Ltd. Appoints Carolyn Bonner as Chief Financial Officer in Addition to Her Role as President

GlobeNewswire